Legal Representation
Attorney
Ann Lamport Hammitte
USPTO Deadlines
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 11, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 11, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 19, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 18, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 16, 2021 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Aug 18, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 16, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 11, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 9, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Feb 9, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 9, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 4, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 2, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 2, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 2, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 6, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 4, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 4, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 4, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 24, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 22, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 22, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 22, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 22, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 22, 2019 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 5, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 8, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 8, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 19, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 20, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 20, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 20, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 20, 2018 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 20, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 13, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 13, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 13, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 15, 2018 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| May 15, 2018 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| May 15, 2018 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| May 7, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 6, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 29, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing
Class 010
Stents; intra-uterine contraceptive devices; catheters; pessaries; coatings sold as an integral component of medical stents and other implantable medical devices
Classification
International Classes
005
010